Methylation of the Polycomb Group Target Genes Is a Possible Biomarker for Favorable Prognosis in Colorectal Cancer

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cancer Epidemiology, Biomarkers and Prevention

• Publication date

  2012-09-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1055-9965.EPI-12-0755PMID 23010642
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Pathways Molecular Pathways : Microsatellite Instability in Colorectal Cancer : Prognostic , Predictive , and Therapeutic Implications

  2012cited by this paper
• Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?

  2012cited by this paper
• Chromosomal instability (CIN) phenotype, CIN high or CIN low, predicts survival for colorectal cancer.

  2012influential reference
• Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.

  2011cited by this paper
• Long-term sedentary work and the risk of subsite-specific colorectal cancer.

  2011cited by this paper
• Genotyping Non-small Cell Lung Cancer (NSCLC) in Latin America

  2011cited by this paper
• RASSF1A methylation is predictive of poor prognosis in female breast cancer in a background of overall low methylation frequency.

  2011cited by this paper
• Analysis of DNA methylation in FFPE tissues using the MethyLight technology.

  2011cited by this paper
• Epigenetics and colorectal cancer

  2011cited by this paper
• Colorectal cancer: molecular features and clinical opportunities.

  2010influential reference
• DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type.

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer.

  2010cited by this paper
• Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia

  2009cited by this paper
• Colorectal cancer: case-control study of sociodemographic, lifestyle and anthropometric parameters in Riyadh.

  2009cited by this paper
• Comprehensive Biostatistical Analysis of CpG Island Methylator Phenotype in Colorectal Cancer Using a Large Population-Based Sample

  2008cited by this paper
• Epigenotyping in Peripheral Blood Cell DNA and Breast Cancer Risk: A Proof of Principle Study

  2008cited by this paper
• Classification of colorectal cancer based on correlation of clinical, morphological and molecular features

  2007cited by this paper
• Widespread Epigenetic Abnormalities Suggest a Broad DNA Methylation Erasure Defect in Abnormal Human Sperm

  2007cited by this paper
• Control of developmental regulators by Polycomb in human embryonic stem cells.

  2006cited by this paper
• CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

  2006cited by this paper
• SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells.

  2003cited by this paper
• Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction.

  2000cited by this paper
• Medullary Thyroid Carcinoma

  2000cited by this paper
• Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.

  1998cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• 17q allele loss is associated with lymph node metastasis in locally aggressive human colorectal cancer

  1995cited by this paper
• APC mutations occur early during colorectal tumorigenesis

  1992cited by this paper
• Identification of a chromosome 18q gene that is altered in colorectal cancers.

  1990cited by this paper
• International Agency for Research on Cancer.

  1985cited by this paper

• Methods in DNA methylation array dataset analysis: A review

  2024cites this paper
• Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers.

  2019cites this paper
• Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma

  2019cites this paper
• Common polymorphic inversions at 17q21.31 and 8p23.1 associate with cancer prognosis

  2019cites this paper
• Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer

  2019cites this paper
• DNA methylation patterns as molecular biomarkers: an overview in colorectal cancer

  2018cites this paper
• Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review

  2018cites this paper
• Diagnostic value of RASSF1A hypermethylation in colorectal cancer: a meta-analysis.

  2018cites this paper
• Prognostic potential of KLOTHO and SFRP1 promoter methylation in head and neck squamous cell carcinoma

  2017cites this paper
• Epigenetic Biomarkers in Colorectal Cancer

  2016cites this paper
• Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma

  2016cites this paper
• STAT3 methylation in white blood cells as a novel sensitive biomarker for the toxic effect of low-dose benzene exposure.

  2016cites this paper
• Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples

  2016cites this paper
• DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer.

  2016cites this paper
• MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors.

  2015cites this paper
• Individualized medicine enabled by genomics in Saudi Arabia

  2015cites this paper
• The Role of Epigenomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools.

  2015cites this paper
• Prognosis Relevance of Serum Cytokines in Pancreatic Cancer

  2015cites this paper
• Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy.

  2015cites this paper
• Pregnancy Exposures Determine Risk of Breast Cancer in Multiple Generations of Offspring

  2015cites this paper
• c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence

  2015cites this paper
• Environmental Epigenetics

  2015cites this paper
• Identification of novel inflammatory serum biomarker signatures associated with pancreatic cancer and molecular characterization of antitumour agents over proliferation and apoptosos in vitro

  2014cites this paper
• The role of epigenetics in colorectal cancer

  2014cites this paper
• Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.

  2014cites this paper
• Physical Activity, Tumor PTGS2 Expression, and Survival in Patients with Colorectal Cancer

  2013cites this paper
• RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma

  2013cites this paper